510(k) Report

510(k) · Cleared

Cleared

14G Cormark Biopsy Site Identifier

K032217510(k) SpecialCleared Aug 21, 200331-day reviewClass II21 CFR 878.4300

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Artemis Medical, Inc. · FZP Clip, Implantable

Cleared on Aug 21, 2003 after a 31-day review. The FDA summary names its predicate without a number. 2 of the 10 devices in its family, counting itself, have a Class I recall. 9 later devices descend from it.

Decided
Aug 21, 2003
Review
31 days
Class
Class II
Product code
FZP
Recalls
None
Predicates
0

9 later devices descend from it, 1 citing it directly. 2 of the 10 devices in this family, counting this one, have a Class I recall.

Descendants, by year cleared 2012: 1 descendant cleared2015: 2 descendants cleared, 2 with a Class I recall22018: 3 descendants cleared2017: 1 descendant cleared2019: 1 descendant cleared2024: 1 descendant cleared200020052010201520202025
  1. This deviceK032217 14G Cormark Biopsy Site IdentifierArtemis Medical, Inc. · 2003
  2. Descendant · cites it directly · 8 of its ownK113202 Tissue MarkerFocal Therapeutics · 2012
  3. Descendant · 2 generations on · 7 of its ownK143484 BioZorb MarkerFocal Therapeutics · 2015 · Recalled (Class I)
  4. Descendant · 3 generations on · 5 of its ownK152070 BioZorb LP MarkerFocal Therapeutics · 2015 · Recalled (Class I)
  5. Descendant · 3 generations on · 1 of its ownK180640 SmartClip Soft Tissue MarkerElucent Medical, Inc. · 2018
  6. Descendant · 4 generations on · 0 of its ownK233639 SmartClip Secure Soft Tissue MarkerElucent Medical, Inc. · 2024

Showing 5 of 9 descendants. See all descendants

Descendants cleared per year

2012: 12015: 22017: 12018: 32019: 12024: 1
2012high 3 (2018) · low 0 (2013)2026

Class I recalls in this family

Most influential descendants

Showing 5 of 9 · See all
  • K113202Tissue MarkerFocal Therapeutics · 2012 · cites it directly8descendants
  • K143484BioZorb MarkerFocal Therapeutics · 2015 · 2 generations on7descendants
  • K152070BioZorb LP MarkerFocal Therapeutics · 2015 · 3 generations on5descendants
  • K180640SmartClip Soft Tissue MarkerElucent Medical, Inc. · 2018 · 3 generations on1descendant
  • K233639SmartClip Secure Soft Tissue MarkerElucent Medical, Inc. · 2024 · 4 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K03221714G Cormark Biopsy Site IdentifierArtemis Medical, Inc.2003—
+1K113202Tissue MarkerFocal Therapeutics2012—
+2K143484BioZorb MarkerFocal Therapeutics2015Class I
+3K152070BioZorb LP MarkerFocal Therapeutics2015Class I
+3K180640SmartClip Soft Tissue MarkerElucent Medical, Inc.2018—
+4K233639SmartClip Secure Soft Tissue MarkerElucent Medical, Inc.2024—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201210
201522
201710
201830
201910
202410
FIG. 1 — Lineage of K032217, 2003–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

2 devices in this family have a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FZP device

  1. #1 K260677 Vessel Closure Device (VCD177213P)score 12.6 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—Caris Site Marker
Named without a submission number
—

What descends from it? (9)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K113202Tissue MarkerFocal Therapeutics20128

Has anything in its family been recalled? (2 Class I)

No FDA recall names this device.

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K143484BioZorb MarkerFocal Therapeutics · 2015 · 2 generations on · ◆ in the 2015 descendants bar of FIG. 11 Class I recall
  • K152070BioZorb LP MarkerFocal Therapeutics · 2015 · 3 generations on · ◆ in the 2015 descendants bar of FIG. 12 Class I recalls

What does this lineage say?

  • Of its descendants, K113202 (Focal Therapeutics, 2012) has gone furthest, with 8 descendants of its own.

How does its category compare?

All FZP devices

FZP Clip, Implantable: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · FZP

5in 2025

2007: 62008: 42009: 32010: 62011: 32012: 22013: 32014: 32015: 82016: 52017: 42018: 42019: 12020: 22022: 32023: 32024: 22025: 52026 (partial year): 2
2007high 8 (2015) · low 0 (2021)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FZP

90in 2025

2007: 31 days median2008: 23 days median2009: 22 days median2010: 47 days median2011: 124 days median2013: 47 days median2014: 29 days median2015: 182 days median2016: 72 days median2017: 29 days median2018: 143 days median2022: 227 days median2023: 65 days median2025: 90 days median
2007high 227 (2022) · low 22 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FZP

1in 2020

2007: 12008: 62010: 12012: 12014: 12016: 22017: 12019: 32020: 1
2007high 6 (2008) · low 0 (2009)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · FZP

1,902in 2025

2007: 1,8772008: 9812009: 2,1602010: 2,3672011: 1,6782012: 1,6772013: 2,3812014: 2,3202015: 2,8712016: 1,8402017: 2,5942018: 2,7182019: 2,9032020: 1,7602021: 1,7592022: 1,5752023: 1,9182024: 2,0672025: 1,902
2007high 2,903 (2019) · low 981 (2008)2025

MAUDE reports naming product code FZP, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200763111,877
20084236981
200932202,160
201064712,367
2011312401,678
20122—11,677
201334702,381
201432912,320
2015818202,871
201657221,840
201742912,594
2018414302,718
20191—32,903
20202—11,760
20210—01,759
2022322701,575
202336501,918
20242—02,067
202559001,902
20262—0—

What is it indicated for?

The 14G CoRMARK™ Biopsy Site Identifier is intended for use during an open surgical or percutaneous breast biopsy procedure to mark the biopsy site.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K032217: 14G Cormark Biopsy Site Identifier.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K032217

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026